Rac GTPase signaling through the PP5 protein phosphatase.
We have investigated the Rac-dependent mechanism of KCNH2 channel stimulation by thyroid hormone in a rat pituitary cell line, GH(4)C(1), with the patch-clamp technique. Here we present physiological evidence for the protein serine/threonine phosphatase, PP5, as an effector of Rac GTPase signaling. We also propose and test a specific molecular mechanism for PP5 stimulation by Rac-GTP. Inhibition of PP5 with the microbial toxin, okadaic acid, blocked channel stimulation by thyroid hormone and by Rac, but signaling was restored by expression of a toxin-insensitive mutant of PP5, Y451A, which we engineered. PP5 is unique among protein phosphatases in that it contains an N-terminal regulatory domain with three tetratricopeptide repeats (TPR) that inhibit its activity. Expression of the TPR domain coupled to GFP blocked channel stimulation by the thyroid hormone. We also show that the published structures of the PP5 TPR domain and the TPR domain of p67, the Rac-binding subunit of NADPH oxidase, superimpose over 92 alpha carbons. Mutation of the PP5 TPR domain at two predicted contact points with Rac-GTP prevents the TPR domain from functioning as a dominant negative and blocks the ability of Y451A to rescue signaling in the presence of okadaic acid. PP5 stimulation by Rac provides a unique molecular mechanism for the antagonism of Rho-dependent signaling through protein kinases in many cellular processes, including metastasis, immune cell chemotaxis, and neuronal development.
Gentile
Saverio
S
Environmental Biology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC 27709, USA.
Darden
Thomas
T
Erxleben
Christian
C
Romeo
Charles
C
Russo
Angela
A
Martin
Negin
N
Rossie
Sandra
S
Armstrong
David L
DL
D000595:Amino Acid Sequence; D000818:Animals; D002460:Cell Line; D000072237:ERG1 Potassium Channel; D004594:Electrophysiology; D051638:Ether-A-Go-Go Potassium Channels; D015640:Ion Channel Gating / Q000187:drug effects; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009687:Nuclear Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D019319:Okadaic Acid / Q000494:pharmacology; D018408:Patch-Clamp Techniques; D010749:Phosphoprotein Phosphatases / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D024642:Potassium Channels, Voltage-Gated / Q000378:metabolism; D020836:Protein Structure, Quaternary; D051381:Rats; D016415:Sequence Alignment; D015398:Signal Transduction; D013963:Thyroid Hormones / Q000494:pharmacology; D014443:Tyrosine / Q000235:genetics / Q000378:metabolism; D020744:rac GTP-Binding Proteins / Q000737:chemistry / Q000378:metabolism*
D000072237:ERG1 Potassium Channel; D051638:Ether-A-Go-Go Potassium Channels; C000606913:KCNH2 protein, human; C000606918:Kcnh2 protein, rat; D009687:Nuclear Proteins; D024642:Potassium Channels, Voltage-Gated; D013963:Thyroid Hormones; D019319:Okadaic Acid; D014443:Tyrosine; D010749:Phosphoprotein Phosphatases; C089641:protein phosphatase 5; D020744:rac GTP-Binding Proteins